{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-034832","form_type":"8-K","ticker":"HROW","cik":"0001360214","company_name":"HARROW, INC.","filed_at":"2023-09-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.700464+00:00","generated_at":"2026-06-10T06:50:12.307371+00:00","sec_items":["5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Harrow Health renames to Harrow, Inc., focusing on eyecare pharmaceuticals","bullets":["Name change from Harrow Health, Inc. to Harrow, Inc. effective September 29, 2023.","Reflects exclusive focus on U.S. ophthalmic pharmaceutical market as part of 5-year strategic plan.","Stockholders not required to approve; rights unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-034832","json":"https://secwatch.observer/filing/0001493152-23-034832.json","markdown":"https://secwatch.observer/filing/0001493152-23-034832.md","text":"https://secwatch.observer/filing/0001493152-23-034832.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1360214/000149315223034832/0001493152-23-034832-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1360214/000149315223034832/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T06:50:12.307371+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6aa8b522c595ad418532e9c349e29556a799c763","claim":"HARROW, INC.: Amended and restated bylaws solely to reflect the name change (effective 2023-09-29).","evidence_excerpt":"On the effective date of the Name Change, the Company also amended and restated its bylaws (the “ Amended and Restated Bylaws ”) solely to reflect the Name Change.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1360214/000149315223034832/0001493152-23-034832-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"bylaw amendment"},{"label":"Effective","value":"2023-09-29"}],"fact_type":"governance_change"},{"claim_id":"994c4e6ea2ef7f8e230d00a6dc08ddc65bbd99ce","claim":"HARROW, INC.: Changed corporate name from Harrow Health, Inc. to Harrow, Inc. via certificate of amendment to the amended and restated certificate of incorporation (effective 2023-09-29).","evidence_excerpt":"Effective as of September 29, 2023, Harrow Health, Inc. (the “ Company ”) changed its corporate name to Harrow, Inc. (the “ Name Change ”) pursuant to a certificate of amendment to the Company’s amended and restated certificate of incorporation filed with the Secretary of State of the State of Delaware.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1360214/000149315223034832/0001493152-23-034832-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2023-09-29"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}